- Home
- HLVX vs CEE Comparison
HLVX vs CEE Comparison
Compare HLVX & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- CEE
- Stock Information
- Founded
- HLVX 2020
- CEE 1990
- Country
- HLVX United States
- CEE Germany
- Employees
- HLVX N/A
- CEE N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- HLVX Health Care
- CEE Finance
- Exchange
- HLVX Nasdaq
- CEE Nasdaq
- Market Cap
- HLVX 104.3M
- CEE 105.5M
- IPO Year
- HLVX 2022
- CEE N/A
- Fundamental
- Price
- HLVX $2.09
- CEE $16.26
- Analyst Decision
- HLVX Hold
- CEE
- Analyst Count
- HLVX 1
- CEE 0
- Target Price
- HLVX $2.00
- CEE N/A
- AVG Volume (30 Days)
- HLVX 647.7K
- CEE 22.0K
- Earning Date
- HLVX 11-06-2025
- CEE 01-01-0001
- Dividend Yield
- HLVX N/A
- CEE 3.86%
- EPS Growth
- HLVX N/A
- CEE N/A
- EPS
- HLVX N/A
- CEE N/A
- Revenue
- HLVX N/A
- CEE N/A
- Revenue This Year
- HLVX N/A
- CEE N/A
- Revenue Next Year
- HLVX N/A
- CEE N/A
- P/E Ratio
- HLVX N/A
- CEE N/A
- Revenue Growth
- HLVX N/A
- CEE N/A
- 52 Week Low
- HLVX $1.34
- CEE $7.80
- 52 Week High
- HLVX $2.17
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- HLVX 55.20
- CEE 48.38
- Support Level
- HLVX $2.07
- CEE $15.00
- Resistance Level
- HLVX $2.11
- CEE $16.66
- Average True Range (ATR)
- HLVX 0.03
- CEE 0.56
- MACD
- HLVX 0.00
- CEE -0.12
- Stochastic Oscillator
- HLVX 57.14
- CEE 43.75
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.